RRPV Solicitation Summary: Rapid Antigen Production for Immunoassay Diagnostics (RAPID)
Health and Human Services, Department of · OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
This notice is not accepting responses (deadline was May 12, 2026, 8:00 PM EDT).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- May 12, 2026, 8:00 PM EDT
- Posted
- Apr 14, 2026
- Solicitation
- RRPV-RPP-26-10-RAPID
- Set-aside
- No Set aside used
- Place of performance
- —
- Contracting office
- BARDA - ASPR / DAAPPO / BARDA DCMA · WASHINGTON · DC
- Source
- SAM.gov · updated May 9, 2026
Description
This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA) entitiled "Rapid Antigen Production for Immunoassay Diagnostics (RAPID)". Through the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP, BARDA seeks to support advanced research and development of rapid antibody and other protein-based molecular recognition reagent generation platforms to enable timely production of immunoassay-ready reagents for diagnostic use. The objective is to establish flexible, end-to-end systems capable of generating high-performance binders against known and emerging biological threats, with the goal of significantly compressing development timelines from pathogen sequence to assay-ready reagents�ideally within weeks. A Proposer�s Conference and Teaming Connect for the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP will take place virtually on Monday, April 27, 2026 from 11am-12pm EST. The full RPP, how to register for the Conference, and information on joining the consortium can be accessed through the RRPV website - www.rrpv.org.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$11.09M
Middle of the pack for similar past awards
Most similar awards fall between $430,061 and $85.38M
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1ADVANCED TECHNOLOGY INTERNATIONAL5 awards$2.27B
- 2ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)1 award$158.81M
- 3START2 GROUP, INC.1 award$138.08M
- 4PPD DEVELOPMENT LP3 awards$115.81M
- 5LUMINARY LABS LLC1 award$100.00M
- 6INTERNATIONAL AIDS VACCINE INITIATIVE INC.1 award$95.59M
- 7BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL1 award$92.50M
- 8KALEO, INC.1 award$33.26M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID b30c5fc7d9cf4a4cbacb330ea689c84b.